October 28, 2004

PALADIN REPORTS RECORD THIRD QUARTER REVENUE
(Also in PDF format)

October 22, 2004

NOTICE OF PALADIN LAB'S THIRD QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

October 18, 2004

PALADIN ANNOUNCES CANADIAN LAUNCH OF OXYTROL^®
(Also in PDF format)

October 4, 2004

PALADIN MAKES GENEROUS DONATION TO HPIC IN SUPPORT OF HUMANITARIAN AID EFFORTS OVERSEAS
(Also in PDF format)

September 30, 2004

PALADIN SIGNS MARKETING AGREEMENT WITH DURAMED PHARMACEUTICALS FOR TWO WOMEN'S HEALTH PRODUCTS
(Also in PDF format)

September 22, 2004

PALADIN REALIGNS PRODUCT PIPELINE AND ANNOUNCES CHANGE TO MANAGEMENT TEAM
(Also in PDF format)

July 29, 2004

PALADIN REPORTS 2004 SECOND QUARTER RESULTS
(Also in PDF format)

July 28, 2004

NOTICE OF PALADIN LAB'S SECOND QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

July 22, 2004

PALADIN FILES NEW DRUG SUBMISSION FOR HISTRELIN HYDROGEL IMPLANT
(Also in PDF format)

July 21, 2004

PALADIN FILES NEW DRUG SUBMISSION FOR GLUCAGEN^®
(Also in PDF format)

June 23, 2004

HEALTH CANADA APPROVES OXYTROL^®, AN INNOVATIVE PATCH FOR OVERACTIVE BLADDER TREATMENT (OAB)
(Also in PDF format)

May 27, 2004

PALADIN SIGNS DISTRIBUTION AGREEMENT WITH OVATION PHARMACEUTICALS FOR TWO CENTRAL NERVOUS SYSTEM DRUGS
(Also in PDF format)

May 18, 2004

HEALTH CANADA PROPOSES AMENDING REGULATIONS TO ALLOW ACCESS TO PLAN B^® WITHOUT A PRESCRIPTION
(Also in PDF format)

May 6, 2004

PALADIN REPORTS 2004 FIRST QUARTER RESULTS
(Also in PDF format)

May 4, 2004

NOTICE OF PALADIN LAB'S FIRST QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

March 3, 2004

PALADIN APPOINTS NEW DIRECTOR
(Also in PDF format)

February 9, 2004

PALADIN SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT FOR REPLAGALT WITH TRANSKARYOTIC THERAPIES, INC.
(Also in PDF format)

February 5, 2004

PALADIN REPORTS 2003 FOURTH QUARTER AND YEAR-END RESULTS
(Also in PDF format)

February 3, 2004

NOTICE OF PALADIN LAB'S FOURTH QUARTER AND YEAR-END RESULTS CONFERENCE CALL
(Also in PDF format)

January 8, 2004

PALADIN ENTERS INTO LICENSING AGREEMENT WITH WATSON FOR OXYTROL^® IN CANADA
(Also in PDF format)